InspireMD (NYSE:NSPR) Receives New Coverage from Analysts at StockNews.com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
TEL AVIV, Israel and MIAMI, April 03, 2024 InspireMD, Inc. , developer of the CGuard™ Embolic Prevention Stent System for the prevention of stroke, today announced that Marvin Slosman, Chief.
Equities research analysts at StockNews.com started coverage on shares of InspireMD (NYSE:NSPR – Get Free Report) in a note issued to investors on Sunday. The brokerage set a “sell” rating on the stock. InspireMD Stock Performance NYSE NSPR opened at $2.37 on Friday. The company has a market capitalization of $55.52 million, a PE ratio […]
Form 8-K InspireMD, Inc. For: Apr 02 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.